Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.38)
# 3,635
Out of 5,241 analysts
177
Total ratings
41.33%
Success rate
-3.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $4.98 | +60.64% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $114.00 | +79.82% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $76.15 | +53.64% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $83.70 | +13.50% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $421.12 | +54.35% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $3.14 | +282.17% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $63.20 | +50.32% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $63.64 | +33.56% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $22.77 | -34.12% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $147.46 | +132.61% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.27 | +1,002.36% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $17.30 | +177.46% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $81.38 | +25.34% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $52.68 | +10.10% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $16.09 | +24.30% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $61.63 | +112.56% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $84.47 | +57.45% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $306.76 | -28.28% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $129.71 | +191.42% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $4.98
Upside: +60.64%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $114.00
Upside: +79.82%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $76.15
Upside: +53.64%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $83.70
Upside: +13.50%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $421.12
Upside: +54.35%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $3.14
Upside: +282.17%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $63.20
Upside: +50.32%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $63.64
Upside: +33.56%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $22.77
Upside: -34.12%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $147.46
Upside: +132.61%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.27
Upside: +1,002.36%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $17.30
Upside: +177.46%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $81.38
Upside: +25.34%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $52.68
Upside: +10.10%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $16.09
Upside: +24.30%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $61.63
Upside: +112.56%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $84.47
Upside: +57.45%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $306.76
Upside: -28.28%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $129.71
Upside: +191.42%